These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25036938)

  • 1. Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart.
    Olivola E; Pierantozzi M; Imbriani P; Liguori C; Stampanoni Bassi M; Conti M; D'Angelo V; Mercuri NB; Stefani A
    PLoS One; 2014; 9(7):e101763. PubMed ID: 25036938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type.
    Volicer L; Direnfeld LK; Freedman M; Albert ML; Langlias PJ; Bird ED
    Arch Neurol; 1985 Feb; 42(2):127-9. PubMed ID: 2579625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and Parkinson's disease: possible role of serotonergic mechanisms.
    Kostić VS; Djuricić BM; Covicković-Sternić N; Bumbasirević L; Nikolić M; Mrsulja BB
    J Neurol; 1987 Feb; 234(2):94-6. PubMed ID: 2435855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Sep; 159(1-2):135-8. PubMed ID: 7505410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms.
    Tong Q; Zhang L; Yuan Y; Jiang S; Zhang R; Xu Q; Ding J; Li D; Zhou X; Zhang K
    Parkinsonism Relat Disord; 2015 Aug; 21(8):882-7. PubMed ID: 26028271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
    Hou C; Jia F; Liu Y; Li L
    Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.
    Stefani A; Pierantozzi M; Olivola E; Galati S; Cerroni R; D'Angelo V; Hainsworth AH; Saviozzi V; Fedele E; Liguori C
    Neurochem Int; 2017 May; 105():58-63. PubMed ID: 28108196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection.
    Kumar AM; Berger JR; Eisdorfer C; Fernandez JB; Goodkin K; Kumar M
    Neuropsychobiology; 2001; 44(1):13-8. PubMed ID: 11408787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.
    Loeffler DA; LeWitt PA; Juneau PL; Camp DM; DeMaggio AJ; Havaich MK; Milbury PE; Matson WR
    Neurochem Res; 1998 Dec; 23(12):1521-5. PubMed ID: 9821156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites.
    Muthane UB; Satishchandra P; Subhash MN
    Mov Disord; 1993 Jul; 8(3):344-8. PubMed ID: 7688076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered serotonin metabolism in depressed patients with parkinson's disease.
    Mayeux R; Stern Y; Cote L; Williams JB
    Neurology; 1984 May; 34(5):642-6. PubMed ID: 6200801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
    Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
    Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients.
    Kuhn W; Müller T; Gerlach M; Sofic E; Fuchs G; Heye N; Prautsch R; Przuntek H
    J Neural Transm (Vienna); 1996; 103(12):1441-5. PubMed ID: 9029411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT and 5-HIAA in cerebrospinal fluid in depression.
    Gjerris A; Sørensen AS; Rafaelsen OJ; Werdelin L; Alling C; Linnoila M
    J Affect Disord; 1987; 12(1):13-22. PubMed ID: 2437171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced platelet 5-HT content is associated with rest tremor in Parkinson's disease.
    Wang JY; Chen JY; Lian YZ; Zhang WY; Wang MY; Liu RP; Chen LH; Zhang X; Zhu JH
    Parkinsonism Relat Disord; 2023 Mar; 108():105314. PubMed ID: 36739793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans.
    Sarrias MJ; Cabré P; Martínez E; Artigas F
    J Neurochem; 1990 Mar; 54(3):783-6. PubMed ID: 1689378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait disorders.
    Iacono RP; Kuniyoshi SM; Ahlman JR; Zimmerman GJ; Maeda G; Pearlstein RD
    J Neural Transm (Vienna); 1997; 104(4-5):451-9. PubMed ID: 9295177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of
    Murakami H; Yamamoto K; Yasumoto T; Kimura A; Sakae Y; Nomoto S; Kubota S; Watanabe D; Watanabe K; Saito Y; Yano S; Ono K
    J Neural Transm (Vienna); 2018 Oct; 125(10):1511-1514. PubMed ID: 30167932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Feb; 150(1):71-4. PubMed ID: 7682308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.